SCHEMBL15455191

SCHEMBL15455191

CCOc1cc(-c2nc3cc(Cl)ccc3s2)ccc1O

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.72
KDM4E B2RXH2 5/20 0.72
NPC1 O15118 3/20 0.72
KMT2A Q03164 3/20 0.72
GLA P06280 2/20 0.72
HTT P42858 1/20 0.54
SMN1; SMN2 Q16637 4/20 0.53
ALDH1A1 P00352 3/20 0.53
HPGD P15428 3/20 0.53
GAA P10253 2/20 0.53
RAB9A P51151 2/20 0.53
PPARG P37231 1/20 0.53
NCOA2 Q15596 1/20 0.53
NCOA1 Q15788 1/20 0.53
SENP7 Q9BQF6 2/20 0.51
CASP3 P42574 1/20 0.51
SENP8 Q96LD8 1/20 0.51
SENP6 Q9GZR1 1/20 0.51
MGAM O43451 1/20 0.50
SI P14410 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15455636 0.86 KDM4E (0.70) MAPTKDM4ENPC1KMT2AGLA
SCHEMBL12470532 0.84 MAPT (1.00) MAPTKDM4ENPC1KMT2AGLA
SCHEMBL15456386 0.83 MAPT (0.68) MAPTKDM4ENPC1KMT2AGLA
SCHEMBL12470524 0.81 GAA (0.60) MAPTKDM4ENPC1KMT2AGLA
SCHEMBL12470894 0.79 KDM4E (0.70) MAPTKDM4ENPC1KMT2AGLA
SCHEMBL4807694 0.77 AHR (0.71) MAPTKDM4ENPC1KMT2AGLA
SCHEMBL11187672 0.77 GAA (0.56) MAPTKDM4ENPC1KMT2AGLA
SCHEMBL15454882 0.77 GAA (0.64) MAPTKDM4ENPC1KMT2AGLA
SCHEMBL12470462 0.76 SMN1; SMN2 (0.52) MAPTKDM4ENPC1KMT2AGLA
SCHEMBL12470432 0.75 MAPT (0.61) MAPTKDM4ENPC1KMT2AGLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9155690-B2 Compound having skin-whitening, anti-oxidizing and PPAR activities and medical use thereof PUSAN NATIONAL UNIVERSITY INDUSTRY-UNIVERSITY COOPERATION FOUNDATION (KR) 2015-10-13 US claimed
US-20150366776-A1 NOVEL COMPOUND HAVING SKIN-WHITENING, ANTI-OXIDIZING AND PPAR ACTIVITIES AND MEDICAL USE THEREOF PUSAN NAT UNIV IND COOP FOUND (KR) 2015-12-24 US disclosed
US-9155690-B2 Compound having skin-whitening, anti-oxidizing and PPAR activities and medical use thereof PUSAN NATIONAL UNIVERSITY INDUSTRY-UNIVERSITY COOPERATION FOUNDATION (KR) 2015-10-13 US disclosed
US-8889881-B2 Compound having skin-whitening, anti-oxidizing and PPAR activities and medical use therefor Pusan National University Industry —University Cooperation Foundation (KR) 2014-11-18 US disclosed
US-20140037564-A1 NOVEL COMPOUND HAVING SKIN-WHITENING, ANTI-OXIDIZING AND PPAR ACTIVITIES AND MEDICAL USE THEREFOR Pusan National University Indusrtyuniversity (KR) 2014-02-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150366776-A1 NOVEL COMPOUND HAVING SKIN-WHITENING, ANTI-OXIDIZING AND PPAR ACTIVITIES AND MEDICAL USE THEREOF PPARG, PPARA, TYR MAPT 1956/4885KDM4E 3430/4885NPC1 3522/4885
US-20140037564-A1 NOVEL COMPOUND HAVING SKIN-WHITENING, ANTI-OXIDIZING AND PPAR ACTIVITIES AND MEDICAL USE THEREFOR PPARG, PPARA, PPARD MAPT 2700/4885KDM4E 3588/4885NPC1 3207/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.